Launching SYNTHIA, a pioneering public-private partnership funded by the Innovative Health Initiative (IHI). The SYNTHIA project, a groundbreaking public-private partnership set to revolutionize the field of personalized medicine by harnessing the power of synthetic data. As the first IHI project to tackle the critical need for privacy-preserving data solutions in healthcare, SYNTHIA aims to propel research and innovation to new heights, ensuring that patients receive the best possible care while safeguarding their personal information. SYNTHIA is a multidisciplinary collaboration of 32 consortium partners - SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts - that will provide a 360º vision on how to advance healthcare applications through SD use Synthetic data, which are artificially generated to mimic real patient data, present a solution to many of the challenges faced in health research today. These data allow researchers to overcome the limitations of access to high-quality, real-world datasets and address growing concerns about patient privacy. However, questions have lingered about the quality and applicability of synthetic datasets, especially in diverse and complex scenarios. SYNTHIA is addressing these challenges head-on by developing validated tools and methods for synthetic data generation (SDG) across various data types, including laboratory results, clinical notes, genomics and imaging. By focusing on six specific diseases the project will demonstrate the utility of synthetic data in advancing personalized medicine: Lung cancer, Breast cancer, Multiple myeloma, Diffuse large B-cell lymphoma, Alzheimer’s disease and Type 2 diabetes. Stay tuned for our press release! This project is supported by the Innovative Health Initiative (IHI) Joint Undertaking (IHI JU) under grant agreement No 101172872. The JU receives support from the European Commission European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA - European Federation of Pharmaceutical Industries and Associations, EuropaBio - the European Association for Bioindustries, MedTechEurope, and VaccinesEurope and DNV. #SYNTHIA_SyntheticData #DataGeneration #FutureOfMedicine #Datascience #EUInnovation #HealthResearch
This is a great project to replicate or expand in Latin America as well !! 🙌🏻
Senior Director Public-Private Partnerships at Novo Nordisk
3moLooking forward to joining this new partnership on synthetic data generation and how this can drive innovation in drug discovery and development, potentially leading to breakthroughs in treating diseases.